Evidence map›Paper›PMID 40903778›Full record

ArticleMicrobial cell factories2025

Amesia nigricolor, a novel endophyte of Encephalartos bubalinus, exhibiting a robust taxol biosynthetic stability: chemical characterization and biological activities.

Asmaa Gamal, Ashraf S A El-Sayed, Eman Fikry, Nora Tawfeek, Azza M El-Shafae, Maher M El-Domiaty

Abstract read
In one paragraph

Article in Microbial cell factories, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Asmaa GamalPharmacognosy Department, Faculty of Pharmacy, Zagazig University, Zagazig, 44519, Egypt.
Ashraf S A El-SayedEnzymology and Fungal Biotechnology Lab (EFBL), Botany and Microbiology Department, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt. ash.elsayed@gmail.com.
Eman FikryPharmacognosy Department, Faculty of Pharmacy, Zagazig University, Zagazig, 44519, Egypt.
Nora TawfeekPharmacognosy Department, Faculty of Pharmacy, Zagazig University, Zagazig, 44519, Egypt.
Azza M El-ShafaePharmacognosy Department, Faculty of Pharmacy, Zagazig University, Zagazig, 44519, Egypt.
Maher M El-DomiatyPharmacognosy Department, Faculty of Pharmacy, Zagazig University, Zagazig, 44519, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diminishing the productivity of Taxol by the potential fungi with storage is the key hurdle that impedes their applications to be an industrial platform for Taxol production. Thus, exploring of a fungal isolate with a reliable robustness for Taxol biosynthesis is the objective of this study. Although, Encephalartos bubalinus has diverse ethnopharmaceutical properties, however, the identity of its endophytic fungi remains poorly explored. Therefore, the endophytic fungi inhabiting this plant has been isolated and characterized, and their Taxol productivity was assessed. Amesia nigricolor OR364127.1, an endophyte of E. bubalinus, was characterized as the potent biologically active and Taxol producer (105 μg/l). The sample identity was resolved from the HPLC, FT-IR and MS/MS analysis, with the molecular mass/ fragmentation pattern was identical to authentic one. The extracted Taxol of A. nigricolor had a strong activity against the HepG2 (IC

Indexed as

EndophytesPaclitaxelAnimalsAntineoplastic Agents, PhytogenicApoptosisChlorocebus aethiopsHep G2 CellsHumansMCF-7 CellsVero CellsAntineoplastic Agents, PhytogenicPaclitaxelAmesia nigricolorAnticancerAnti-wound healing activityEncephalartos bubalinusTaxol

Identifiers

PMID40903778
PMCPMC12406444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.